# Healthy Body, Healthy Bones After Bariatric Surgery Trial

> **NCT04279392** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 10 (actual)

## Conditions studied

- Bariatric Surgery Candidate
- Bone Loss
- Bone Resorption

## Interventions

- **DRUG:** Zoledronic Acid 5 mg/Bag 100 ml Inj
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04279392
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04279392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04279392, "Healthy Body, Healthy Bones After Bariatric Surgery Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04279392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*